0001213900-19-014041.txt : 20190730
0001213900-19-014041.hdr.sgml : 20190730
20190730170712
ACCESSION NUMBER: 0001213900-19-014041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190729
FILED AS OF DATE: 20190730
DATE AS OF CHANGE: 20190730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Paul Edward
CENTRAL INDEX KEY: 0001658544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55347
FILM NUMBER: 19986338
MAIL ADDRESS:
STREET 1: 300 EAST 56TH STREET, APT 19E
CITY: NEW YORK,
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0306
4
2019-07-29
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001658544
Kelly Paul Edward
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR
NEW YORK,
NY
10022
1
0
0
0
Options to purchase common stock
2.20
2019-07-29
4
A
0
600000
2.20
A
2029-07-29
Common Stock
600000
600000
D
Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.
/s/ Paul E. Kelly
2019-07-30